1. Mechanism for the Action of Bone Morphogenetic Proteins and Regulation of Their Activity
2. Cell responses to bone morphogenetic proteins and peptides derived from them: Biomedical applications and limitations
3. US Food and Drug Administration, InFUSE Bone Graft/LT-CAGE Lumbar Tapered Fusion Device, P000058 approval letter. http://www.accessdata.fda.gov/cdrh_docs/pdf/P000058a.pdf, 2002; http://www.accessdata.fda.gov/cdrh_docs/pdf/P000058a.pdf[Online; accessed 01-Jul-2010].
4. US Food and Drug Administration, INFUSE Bone Graft, P000054 approval letter. http://www.accessdata.fda.gov/cdrh_docs/pdf/p000054a.pdf, 2004; http://www.accessdata.fda.gov/cdrh_docs/pdf/p000054a.pdf[Online; accessed 01-Jul-2010].
5. US Food and Drug Administration, INFUSE Bone Graft, P050053 approval letter. http://www.accessdata.fda.gov/cdrh_docs/pdf5/p050053a.pdf, 2007; http://www.accessdata.fda.gov/cdrh_docs/pdf5/p050053a.pdf[Online; accessed 01-Jul-2010].